Browse by category

ANSM suspends Allurion gastric balloons in France

The Agence nationale de sécurité du médicament et des produits de santé (ANSM, National Medicines Safety Agency) in France has suspended...

FDA grants Breakthrough Device Designation for Fractyl’s Revita in weight maintenance for people with obesity who discontinue GLP-1s

The FDA has granted Breakthrough Device Designation (BDD) for Fractyl Health’s Revita System for use in the maintenance of weight loss...

Phenomix launches personalised obesity care genetic testing available to women in with Hello Alpha partnership

Phenomix Sciences has entered a partnership with Hello Alpha, a virtual primary care platform, to enable women to take control of their...

ReShape Lifesciences sells obesity devices to Biorad Medisys

ReShape has entered into an asset purchase agreement with Biorad Medisys, which is party to a previously disclosed exclusive license...

iHerb launches new GLP-1 support products designed to combat common side effects from rapid weight loss

iHerb has launched three new supplements specifically designed to support individuals using semaglutide (GLP-1 agonists) by addressing...

WHO issues warning on falsified medicines as Lilly warns patients about counterfeit and compounded medicines

The World Health Organization (WHO) has issued a medical product alert on falsified semaglutides, the type of medicines that are used for...

Unjury Protein launches Protect & Restore Advanced Protein+ to reduce side effects of GLP-1 RAs

Unjury Protein has launched its Protect & Restore Advanced Protein+ - the first clinically supported medical food and co-therapy for...

Aphaia Pharma completes enrolment of phase 2 trial in individuals with obesity

Aphaia Pharma, a clinical-stage company harnessing precision-targeted drug formulations to restore endogenous endocrine balance for the...

Scottish Medicines Consortium accepts tirzepatide (Mounjaro) for obesity in eligible adults

The Scottish Medicines Consortium (SMC) has accepted Eli Lilly and Company’s tirzepatide (Mounjaro) for restricted use within NHS...

Karl Storz to acquire Asensus Surgical

Asensus Surgical has entered into a definitive merger agreement with Karl Storz Endoscopy-America, a wholly owned direct subsidiary of...

1 2

4 5

Reduced complication-related costs and enhanced patient recovery using the Ezisurg Endostapler

2 days ago

Fractyl unveils promising preclinical data demonstrating safety and feasibility of local delivery of RJVA-001 Rejuva Smart GLP-1 Pancreatic Gene Therapy

5 days ago

Researchers to develop BIOSYNC wireless bioelectronic device to treat obesity and diabetes

6 days ago

Browse by category

Browse by tag

Weekly Digest

Get a round-up of the main headlines from Bariatric News, directly to your inbox each week.

Get in touch!
Email: info@bariatricnews.net